Markets:

Overview

News

Currencies

International

Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

0.9027 +0.0444 (+5.17%)

Streaming Delayed Price Updated: 1:43 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hoth Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

HOTH Stock Alert: Why Is Hoth Therapeutics Skyrocketing Today? ↗

January 04, 2022

Investors in Hoth Therapeutics and HOTH stock have seen their investment go parabolic today on a key update for one of the company's drugs.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 04, 2022

Gainers Hoth Therapeutics (NASDAQ:

Via Benzinga

Why Hoth Therapeutics Stock Is Soaring Today? ↗

January 04, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) announced proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic potential of...

Via Benzinga

Dow, S&P 500 Nab Intraday Highs as Bond Yields Rise ↗

January 04, 2022

The Dow Jones Industrial Average is up 242 points midday, pacing for another record close. The S&P 500 Index also hit an intraday record this morning but has since joined the tech-heavy Nasdaq...

Via Talk Markets

Global Alzheimer’s Disease Therapeutics Market Projected To Generate Revenue Of $9.97 Billion By 2028

January 04, 2022

Palm Beach, FL –January 4, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease is a degenerative, progressive ailment that attacks the brain’s nerve cells, resulting in memory loss,...

Via FinancialNewsMedia

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 04, 2022

Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $28....

Via Benzinga

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Positive Results - Reduce Amyloid β in Alzheimer's Disease ↗

January 04, 2022

Significant decrease in Aβ after acute treatment with HT-ALZ, supporting that HT-ALZ has the potential to modify Aβ plaque formation in the...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 03, 2022

Gainers Indaptus Therapeutics (NASDAQ:INDP

Via Benzinga

Hoth Therapeutics Announces Submission of Orphan Designation Application for HT-KIT to Treat Mastocytosis ↗

December 21, 2021

NEW YORK, NY December 21, 2021 /PRNewswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH) a patient-focused clinical-stage biopharmaceutical company, announced...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 20, 2021

Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD

Via Benzinga

Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options

December 21, 2021

Palm Beach, FL –December 21, 2021 – FinancialNewsMedia.com News Commentary – Systemic mastocytosis is rare disease which affects very few people and it causes due to C-kit mutation which leads to...

Via FinancialNewsMedia

Hoth Therapeutics Reports Finishing Up a Busy Year of Research Across its Portfolio of Drug Candidates ↗

December 20, 2021

Image provided by Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

EXCLUSIVE: Hoth Therapeutics Gives Cannabinoid-Based Lupus Candidate Back To Zylö ↗

December 08, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has agreed to license its cannabinoid therapeutic, HT-005, for lupus patients back to Zylö Therapeutics. What Happened: In August 2019,...

Via Benzinga

Systemic Lupus Erythematosus Treatment Market Projected To Reach $3.56 Billion By 2027

December 08, 2021

Palm Beach, FL –December 8, 2021 – FinancialNewsMedia.com News Commentary – Systemic Lupus Erythematosus is also known as lupus. It is an autoimmune disease that affects all parts of your body. The...

Via FinancialNewsMedia

Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics ↗

December 07, 2021

Image Provided By Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 01, 2021

Gainers Hoth Therapeutics (NASDAQ:HOTH) s...

Via Benzinga

Increased Prevalence of Atopic Dermatitis Fueling Impressive Growth for Atopic Dermatitis Drugs

November 30, 2021

Palm Beach, FL –November 30, 2021 – FinancialNewsMedia.com News Commentary – Atopic dermatitis is a chronic inflammatory skin condition characterized by red, itchy, swollen, and broken skin. White...

Via FinancialNewsMedia

EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa ↗

November 30, 2021

Hoth Therapeutics Inc (NASDAQ: HOTH) has begun enrollment and dosing for the second cohort in its Phase 1b trial of topical BioLexa to treat mild to moderate atopic...

Via Benzinga

Global Cancer Therapy Market Expected to Reach $268 Billion In 2026, With A CAGR Of 9.15%

November 16, 2021

Palm Beach, FL –November 16, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic has affected the healthcare systems globally and also has a significant impact on the cancer therapy...

Via FinancialNewsMedia

Hoth Inks Research Agreement With North Carolina State University For Study of Preclinical Candidate To Treat Mast Cell Cancers ↗

November 16, 2021

Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced an oncology R&D collaboration on Tuesday. What Happened: New York-based Hoth, a biopharma focusing on new-age therapies for...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 16, 2021

Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...

Via Benzinga

Hoth Therapeutics Enters Into Agreements with WuXi STA; Attempts to Get New Cancer Treatment Closer to Clinical Trials ↗

November 11, 2021

Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...

Via Benzinga

This Company Says Its New Topical Therapy Trials Bringing Hope to People Exposed to Biofilm Bacteria ↗

November 09, 2021

Photo by Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...

Via Benzinga

Clinical-Stage Biopharmaceutical Company HOTH Says It Is on a Mission to Develop Next-Generation Therapeutics to Meet Patient Needs ↗

November 03, 2021

Photo by Roberto Sorin on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Hoth Therapeutics Says the Possibilities Could Be Endless ↗

October 28, 2021

Photo by Hoth Therapeutics The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...

Via Benzinga

Global Atopic Dermatitis Treatment Market Size Is Projected To Be Worth US$21.80 Billion By 2026

October 12, 2021

Palm Beach, FL –October 12, 2021 – FinancialNewsMedia.com News Commentary – Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually...

Via FinancialNewsMedia

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis in Humans ↗

October 12, 2021

NEW YORK, NY /PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that is has received Human Research Ethics...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

Alkido Pharma Trading 30% Below Cash Value Despite Positive Indications ↗

October 06, 2021

Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which revealed the strongest balance...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

All News about Hoth Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today